Chinese court rules against an AI platform for copyright infringement for the first time; the U.S. Department of Commerce opens consultation for the restrictions on Chinese electrical vehicles; and Chinese IP Court imposes punitive damages to stop seed IP infringement
In 2023, the healthcare industry in China was subject to significant legislative advancements and reforms aimed at addressing industry concerns and promoting innovation. Hanshuo Zhou and Xiaoyun Wang of Jingtian & Gongcheng summarize the key events, and provide a reflective review based on their' practical experience
Shanghai plans a three-tiered cross-border data flow regime in the Lingang free trade zone to boost foreign investment; the U.S. proposes a "know your customer" regulation for cloud computing companies over China AI concerns; and a bill introduced in Congress called the BIOSECURE Act, is designed to broaden current sanctions on China
U.S. Commerce official expects higher penalties for violations of U.S. export controls; Shein must satisfy both the U.S. and China to pull off its IPO; and U.S. lawmakers work to further limit U.S. investment in Chinese tech sector.
In 2023, significant U.S. restrictions were placed on Chinese interests. Charles Wu of Clyde & Co reviews the legislative changes, and offers practical insights into their potential impact, and the path forward in 2024
2023 was a significant year for the development of legislation and case law on intellectual property rights in China, as explored by Aggie Liu, Partner, and Hao Meng, Associate, from FenXun, which operates a joint legal platform with Baker McKenzie in China
